Related Experiment Videos
Liver damage in HIV-infected patients
1Department of Infectious Diseases, Pomeranian University of Medicine, Szczecin, Poland. annabk@inet.com.pl
Summary
Hepatitis C virus (HCV) and hepatitis B virus (HBV) co-infections are common in HIV patients, often presenting with mild liver disease. This study analyzed clinical, biochemical, and histopathological data to understand hepatic disorders in this population.
Area of Science:
- Hepatology
- Infectious Diseases
- Virology
Background:
- Human Immunodeficiency Virus (HIV) infection can lead to various hepatic complications.
- Co-infection with hepatitis B virus (HBV) and hepatitis C virus (HCV) is prevalent in HIV-positive individuals.
- Understanding the spectrum of liver disease in HIV patients is crucial for management.
Purpose of the Study:
- To investigate hepatic disorders in a cohort of HIV-infected patients.
- To analyze clinical, biochemical, serological, and histopathological data related to liver health.
- To determine the prevalence and characteristics of HBV and HCV co-infections in this population.
Main Methods:
- Retrospective analysis of 125 HIV-infected patients (mean age 30.2 years).
- Data collected included clinical presentation, liver function tests, serological markers for HBV and HCV, and liver biopsy results.
- Patients were categorized based on risk factors (intravenous drug use vs. sexual contact) and AIDS diagnosis.
Main Results:
- Hepatomegaly observed in 49.6% of patients; elevated AST levels in 88%.
- HCV antibodies detected in 56.8%, HBV history in 48.8%, and 32% had markers for both.
- Liver biopsies in 36 patients revealed abnormalities in 88%, with chronic viral hepatitis in 37.1% of biopsied cases.
Conclusions:
- HCV and HBV co-infection are frequently observed in HIV-infected patients.
- Liver disease in this cohort is often asymptomatic or mildly symptomatic.
- Hepatic disorders in HIV patients result from diverse etiopathogenic factors.